|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 37, 34722-34727, September 14, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, January 25, 2001, and in revised form, July 10, 2001
The ryanodine receptor of Jurkat T lymphocytes
was phosphorylated on tyrosine residues upon stimulation of the cells
via the T cell receptor/CD3 complex. The tyrosine phosphorylation was transient, reaching a maximum at 2 min, and rapidly declined
thereafter. In co-immunoprecipitates of the ryanodine receptor, the
tyrosine kinases p56lck and
p59fyn were detected. However, only
p59fyn associated with the ryanodine receptor
in a stimulation-dependent fashion. Both tyrosine kinases,
recombinantly expressed as glutathione S-transferase (GST)
fusion proteins, phosphorylated the immunoprecipitated ryanodine
receptor in vitro. In permeabilized Jurkat T cells, GST-p59fyn, but not
GST-p56lck, GST-Grb2, or GST alone,
significantly and concentration-dependently enhanced
Ca2+ release by cyclic ADP-ribose. The tyrosine kinase
inhibitor PP2 specifically blocked the effect of
GST-p59fyn. This indicates that intracellular
Ca2+ release via ryanodine receptors may be modulated by
tyrosine phosphorylation during T cell activation.
Ryanodine receptors
(RyR)1 are large tetrameric
Ca2+ channel-forming proteins. Three different isoforms of
RyR have been identified, termed types 1, 2, and 3 (also known as
skeletal muscle type RyR, cardiac muscle type RyR, and brain type RyR
(reviewed in Ref. 1)). There is indeed abundant expression of these
particular isoforms in the respective tissues, but there is also
increasing evidence for low expression of different RyR in other
tissues (2).
In skeletal and cardiac muscle, RyR are the major intracellular
Ca2+ release channels, which control contractility by
Ca2+-induced Ca2+ release (reviewed in Ref. 3).
In neuronal cells, Ca2+ release via RyR is involved in
fundamental brain function, such as long term depression (4).
Ca2+ release via RyR is controlled by Ca2+
itself (5). In addition, investigations in different cell systems
suggest that the cyclic nucleotide cADPR may also function as an
endogenous ligand for RyR-mediated Ca2+-release
(reviewed in Refs. 6 and 7).
Activation of T lymphocytes is a fundamental part of the immune system
to ensure protection against foreign antigens. One of the intracellular
signaling pathways essentially necessary for T cell activation is a
sustained elevation of [Ca2+]i
(reviewed in Ref. 8). The sustained elevation of [Ca2+]i results in activation of
many proteins (reviewed in Ref. 9). Of particular interest is the
protein phosphatase calcineurin, which, upon activation by
Ca2+/calmodulin, dephosphorylates the transcription factor
nuclear factor of activated T cells (10). Only this dephosphorylated form of nuclear factor of activated T cells can enter the nucleus to
activate multiple gene expression, e.g. expression of
interleukin-2 (10).
Among the first biochemical events that are observed during T cell
activation is phosphorylation of multiple proteins on tyrosine residues. These phosphorylation events are mediated by a concerted action of several protein-tyrosine kinases (PTK), including Src family
PTKs p56lck and p59fyn
(11-14).
Recently, we have provided evidence that cADPR and RyR play an
important role in the sustained phase of Ca2+ signaling in
T cells (15). Since TCR/CD3 complex-mediated Tyr phosphorylation of the
type 1 Ins(1,4,5)P3 receptor has been described recently
(16), in this study we investigated (i) whether also RyR might be
phosphorylated on tyrosine residues in a
stimulation-dependent fashion, and (ii) whether such
tyrosine phosphorylation might have a functional effect on
Ca2+ release via RyR.
Materials--
Antibodies and antisera were obtained as follows:
anti-RyRcommon mouse monoclonal antibody (mAb) from
Calbiochem, Eggenstein, Germany; anti-RyRcommon antiserum
(no. C-18) from Santa Cruz Biotechnology, Heidelberg, Germany;
anti-phosphotyrosine mAb (clone PY 99) from Santa Cruz Biotechnology;
anti-phosphotyrosine antiserum (rabbit polyclonal IgG) from Upstate
Biotechnology, Lake Placid, NY, obtained via Biomol, Hamburg, Germany;
anti-p56lck mAb (clone 3A5) and
anti-p59fyn (clone 15) both from Santa Cruz
Biotechnology. The Src-type PTK inhibitor PP2
(4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine; Ref. 17) was obtained from Calbiochem, Eggenstein, Germany.
All other chemicals used were of the highest purity grade available.
MilliQ water (Millipore Waters, Eschborn, Germany) was used for the
preparation of all buffers.
Cell Culture--
Jurkat T lymphocytes (subclone JMP) were
cultured as described previously (18) in RPMI 1640 medium containing
Glutamax I (Life Technologies, Eggenstein, Germany), buffered by HEPES
(20 mM, pH 7.4) and supplemented with newborn calf serum
(7.5%), penicillin (100 units/ml), and streptomycin (50 µg ml; all
from Life Technologies). The cells were cultured at 37 °C in a
humidified atmosphere in the presence of 5% CO2.
Localization of RyR by Confocal Microscopy--
The cells were
fixed using 2% (w/v) p-formaldehyde in buffer A containing
(mM) 140 NaCl, 5 KCl, 1 MgSO4, 1 CaCl2, 1 NaH2PO4, 5.5 glucose, and 20 HEPES
(pH 7.4) for 15 min at room temperature. Then, the cells
were rinsed twice with buffer A. Permeabilization was carried out by
incubation in methanol for 5 min at room temperature. Afterwards, the
cells were again rinsed twice with buffer A. Subsequently, the cells
were incubated with anti-RyRcommon mAb (Calbiochem) at 1 µg/100 µl for 60 min at room temperature. Then, excess of mAb was
removed by rinsing the cells twice with buffer A. Finally, a secondary
fluorescein isothiocyanate-labeled goat anti-mouse antiserum (Molecular
Probes Europe, Leiden, The Netherlands) was added at 4 µg/100 µl
for 60 min at room temperature in the dark. Then, excess of the
antiserum was removed by rinsing the cells twice with buffer A. Cells
stained in this way were kept on ice in the dark until use (usually
within the next 90 min).
Confocal microscopy was performed using a monochromator-based imaging
system (Improvision, Heidelberg, Germany) built around a Leica DM IRBE
microscope at 100-fold magnification. Images were taken with a 12 bit
gray-scale CCD camera (type C4742-95-12NRB; Hamamatsu, Enfield, United
Kingdom) on 30 consecutive horizontal (z) planes, each 0.5 µm, from the bottom to the top of the cell. The spatial resolution in
the horizontal plane (xy plane) of the camera was 0.067 µm/pixel. Excitation wavelength was 485 nm, and emission light was
filtered at 525 nm. Raw data images were stored on hard disk. To obtain
digital confocal images, mathematical deconvolution based on the
point-spread algorithm was carried out using the Openlab Confocal
Imaging software module (Ref. 19; Improvision, Heidelberg, Germany).
Usually, deconvolution was carried out using two or three neighbors on
each side of the central horizontal plane of the cell; the magnitude
setting of removal of stray light was 0.2300-0.2400 (on a scale
between 0 (no removal) and 0.9999 (complete removal of stray light)).
Preparation of the Subcellular Fraction P10 from Jurkat T
Lymphocytes--
The cells (109 lymphocytes) were
harvested, centrifuged twice (500 × g, 5 min, room
temperature), and washed twice in 5 ml of 20 mM HEPES (pH
7.5), 110 mM NaCl. Following an incubation period of 20 min
at 37 °C, the cells were homogenized on ice in the presence of
protease inhibitors (AEBSF, 500 µM; leupeptin, 20 µM; pepstatin, 1 µM; antipain, 10 µM) and dephostatin (100 µM) using a tight
Potter-Elvehjem homogenizer (1500 units/min, 30 strokes). All further
steps were carried out at 4 °C. After removal of cell debris and
unbroken cells by low speed centrifugation (500 × g,
10 min), the supernatant was ultracentrifuged (20 min, 10000 × g, 4 °C) to obtain the membrane fraction P10. This
fraction was stored in aliquots at Protein Assay--
For protein determination the Bio-Rad protein
assay (Bio-Rad, München, Germany) was used as microassay with
bovine serum albumin (fraction V; Sigma, Deisenhofen, Germany) as standard.
Immunoprecipitation of RyR--
RyR from P10 membranes, known to
be the major source for RyR in Jurkat T cells (15), were solubilized by
addition of lysis buffer (25 mM HEPES, pH 7.2, 150 mM NaCl, 0.25% CHAPS (w/v), protease inhibitors as above).
20 µg of anti-RyRcommon mAb (Calbiochem) or
anti-RyRcommon polyclonal antiserum (Santa Cruz) were
coupled to Protein G-Sepharose (50 µl of a 50% (w/v) suspension) in
500 µl of lysis buffer (1.5 h, 4 °C, continuous shaking).
Anti-RyRcommon coupled to Protein G-Sepharose (50 µl) was
then incubated with solubilized P10 membranes (400 µg of protein) in
lysis buffer for 1.5 h at 4 °C under continuous shaking. Then,
the Protein G-Sepharose beads were centrifuged (13,000 × g, 1 min, 4 °C), the supernatant was discarded, and the
immunoprecipitate rinsed with lysis buffer; the washing procedure was
then repeated three times (for co-precipitation experiments, two times).
Western Blotting--
Immunoprecipitated RyR protein was boiled
at 95 °C for 5 min and subjected to SDS-PAGE in a 6% gel (3%
stacking gel) under reducing conditions. To ensure migration of the
large RyR subunits (~550 kDa) into the gel, the gel run was extended
for another 60 min after the bromphenol blue band had reached the end
of the gel. In co-immunoprecipitation experiments, 7.5% polyacrylamide gels were used; also, in these experiments, gel runs were terminated as
soon as the bromphenol blue band had reached the end of the gel.
Proteins were subsequently transferred onto nitrocellulose sheets by
tank blotting (18 h, 550 mA constant, 4 °C). The nitrocellulose sheets were blocked with fatty acid-free milk powder (5% w/v in TBS
buffer (1.4 M NaCl, 0.1 M Tris-HCl, pH 8.0)
with 0.5% Tween 20) for 1 h at room temperature, and
immunostained with the primary antibody (in TBS buffer with
0.5% Tween 20) for 18 to 24 h at 4 °C. Concentrations of the
primary antibodies were: (i) anti-RyRcommon mAb, 5 µg/ml;
(ii) anti-phosphotyrosine mAb PY99, 1 µg/ml; (iii) anti-phosphotyrosine antiserum, 2 µg/ml; (iv)
anti-p56lck mAb, 1 µg/ml; (v)
anti-p59fyn mAb, 1 µg/ml. Then, the membrane
was incubated in TBS with 0.5% Tween 20 and 2.5% (w/v) fatty
acid-free milk powder three times for 10 min. Subsequently, horseradish
peroxidase-labeled goat anti-mouse antiserum (Dianova, Hamburg,
Germany) was added (dilution in TBS with 0.5% Tween 20 and 2.5% (w/v)
fatty acid-free milk powder as recommended by the manufacturer,
e.g. 1:2000 to 1:10,000) for 1 h at room temperature.
Then, the following washing procedure was carried out with the
membrane: two times briefly with TBS, two times for 10 min in TBS with
0.5% Tween 20, for 10 min in TBS with 3% Tween 20, two times for 15 min in TBS with 0.5% Tween 20, two times for 30 min in TBS with 0.5%
Tween 20, and two times for 30 min in TBS alone. Finally, the blots
were developed using the ECL kit (Amersham Pharmacia Biotech) according
to the manufacturer's instructions.
In Vitro Tyrosine Phosphorylation of RyR--
P10 membranes were
prepared from unstimulated Jurkat T cells as described above. The
membrane pellet was resuspended in kinase buffer (20 mM
MOPS, pH 7.0, 5 mM MgCl2, 5 mM
MnCl2, 150 mM NaCl) at 10 mg of protein/ml, and
500 µl of the suspension were incubated with 1 µg of recombinant
GST-p56lck or GST-p59fyn
(20) in the presence of 1 mM ATP at 37 °C. To terminate
the incubation, protein samples (100 µl) were removed and rapidly frozen in liquid nitrogen. The samples were then solubilized (0.25% CHAPS, w/v) and subjected to immunoprecipitation using
anti-RyRcommon mAb (Calbiochem) and SDS-PAGE in a 6% gel
(3% stacking gel) under reducing conditions. Western blotting using
anti-Tyr(P) mAb (PY99) was carried out as described above.
Ca2+ Release Assay in Permeabilized
Jurkat T Cells--
Jurkat T cells were permeabilized as described (21)
with the following modifications: saponin concentration (final) 40 µg/ml, incubation period with saponin 17.5 or 20 min.
Measurements with 900 µl of cell suspension (containing ~1.2 × 107 permeabilized cells) in the presence of 1 µM fura2/free acid were carried out in standard quartz
fluorescence cuvettes and were started by addition of creatine kinase
(20 units/ml final concentration) and creatine phosphate (20 mM final concentration). Fluorescence was recorded in a
Hitachi F2000 instrument with wavelength settings of 340 and 380 nm for
excitation (alternating) and 495 nm for emission.
Subsequent addition of ATP (1 mM final concentration)
completed uptake of Ca2+ ions into stores, and the
resulting basal Ca2+ concentration was usually between 100 and 500 nM, depending on the individual preparation. At the
beginning of each series of experiments, the quality of the
permeabilized cell preparation was checked by its responsiveness to
Ins(1,4,5)P3 (4 µM final concentration) and
cADPR (10 µM final concentration). Chelex resin (Sigma)
was added generally to reagent solutions, e.g. cADPR, Ins(1,4,5)P3, GST fusion proteins, to remove contaminations
of Ca2+.
Jurkat T lymphocytes express the RyR as shown by
immunoprecipitation and Western blotting (Fig.
1A), and confocal microscopy (Fig. 1B). The amount of RyR detected by an
anti-RyRcommon mAb did not change significantly within the
first minutes upon stimulation of the TCR/CD3 complex (Fig.
1A). When 10,000 × g membranes were prepared in the presence of the Tyr phosphatase inhibitor dephostatin (100 µM), a transient phosphorylation of Tyr residues of
the RyR in response to stimulation of the TCR/CD3 complex was observed (Fig. 1A).
Using anti-RyRcommon mAb and a fluorescein
isothiocyanate-labeled goat anti-mouse antiserum as secondary antibody
in confocal microscopy, the main localization of the RyR was found to
be close to the plasma membrane in permeabilized Jurkat cells (Fig.
1B). In intact cells, no staining was observed (data not
shown). Similar results were obtained using
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-ryanodine (Molecular
Probes) for staining (data not shown). These results indicate that RyR
are localized within membrane systems close to the inner surface of the
plasma membrane.
Phosphorylation of Tyr residues of the RyR was transient, showing
marked phosphorylation at 2 min (Fig. 1A). A more detailed analysis of the time course revealed very weak phosphorylation by 15 and 30 s, whereas substantial phosphorylation was observed at 1 and 2 min (Fig. 1C). At later time points, e.g. 5 min (Fig. 1A) or 10 or 20 min (data not shown), no
phosphorylation on Tyr residues could be detected. These results were
obtained with two different anti-phospho-Tyr antibodies, the mAb PY99
(Santa Cruz Biotechnology) and a polyclonal anti-phosphotyrosine
antiserum (rabbit polyclonal IgG; Upstate Biotechnology).
Membrane distribution of RyR, taken together with an extremely rapid
kinetics of its tyrosine phosphorylation following TCR/CD3 ligation,
implicated p59fyn and
p56lck in this event. These PTKs are localized
to the membrane due to their N-terminal myristoylation (22, 23) and
palmitoylation (24, 25); are constitutively associated with the
intracellular domains of several surface proteins, including TCR/CD3
(p59fyn) and CD4 (p56lck)
(26, 27); and respond very rapidly to TCR/CD3 stimulation (12, 28).
Therefore, p59fyn and
p56lck are candidates to be involved in Tyr
phosphorylation of the RyR.
To identify PTK(s) phosphorylating RyR in Jurkat T cells,
co-immunoprecipitation experiments using anti-RyR antiserum were carried out (Fig. 2). In addition to
tyrosine phosphorylation of the RyR (Fig. 2, left
panel, 2-min time point), marked Tyr phosphorylation of a
band (or a double band) near 55-60 kDa was detected in RyR
immunoprecipitates (Fig. 2, left panel). The time course of phosphorylation of this band/double band was more rapid as
compared with Tyr phosphorylation of the RyR itself (Fig. 2, left panel), thus being consistent with the idea
that this band represents the PTK(s) associated with and
phosphorylating RyR. Analysis of RyR immunoprecipitates for individual
PTKs demonstrated that p59fyn and
p56lck were associated with RyR in Jurkat T
cells. Interestingly, p59fyn was not found in
RyR immunoprecipitate from unstimulated cells, but was co-precipitated
in a time- and stimulation-dependent fashion (Fig. 2,
middle panel). The same experiment carried out
for p56lck showed co-immunoprecipitation at all
time points, regardless of whether the cells had been stimulated or not
(Fig. 2, right panel).
Transient Tyrosine Phosphorylation of Human Ryanodine Receptor
upon T Cell Stimulation*
§,
, and
Division of Cellular Signal Transduction,
Institute for Medical Biochemistry and Molecular Biology, University of
Hamburg, University Hospital Eppendorf, Martinistrasse 52, D-20246
Hamburg, Germany and the ¶ Department of Microbiology and
Immunology, Temple University School of Medicine,
Philadelphia, Pennsylvania 19140
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
70 °C.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (59K):
[in a new window]
Fig. 1.
Tyrosine phosphorylation of the RyR in
response to stimulation of the TCR/CD3 complex. Jurkat T
lymphocytes were stimulated by anti-CD3 mAb OKT3 (10 µg/ml) for the
times indicated (A and C), the cells were
homogenized, and P10 membranes were prepared in the presence of
dephostatin (100 µM) as described under "Experimental
Procedures." P10 membranes were solubilized in lysis buffer (25 mM HEPES, pH 7.2, 150 mM NaCl, 0.25% CHAPS
(w/v), 500 µM AEBSF, 20 µM leupeptin, 1 µM pepstatin, 10 µM antipain),
immunoprecipitated with anti-RyRcommon polyclonal antiserum
and separated by SDS-PAGE (3% stacking gel, 6% separation gel). The
mass of protein in individual lanes corresponds to the mass of RyR
immunoprecipitated by 4 µg of anti-RyRcommon polyclonal
antiserum in case of anti-RyR Western blot (A,
three lanes on the left
side; C, five lanes on the
right side) and to 1 µg of
anti-RyRcommon polyclonal antiserum in case of
anti-phosphotyrosine Western blot (A, three
lanes on the right side; C,
five lanes on the left
side). Subsequent tank blotting and immunostaining were
carried out as described under "Experimental Procedures."
Antibodies used for immunostaining: A,
anti-RyRcommon mAb (Calbiochem) and anti-phosphotyrosine
rabbit polyclonal antiserum (Upstate Biotechnology); C,
anti-RyRcommon mAb (Calbiochem) and anti-phosphotyrosine PY
99 (Santa Cruz). B, confocal microscopy was carried out as
described under "Experimental Procedures" using cells fixed with
p-formaldehyde and permeabilized by methanol.
Anti-RyRcommon mAb (Calbiochem) was used as primary and
fluorescein isothiocyanate-labeled goat anti-mouse antiserum as
secondary antibody. Raw images were obtained at 100-fold magnification,
and confocal images were calculated using the point-spread algorithm.
For comparison, the bright field image of the cell is shown in the
upper part of B.

View larger version (32K):
[in a new window]
Fig. 2.
Tyrosine phosphorylation of
p56lck and
p59fyn co-immunoprecipitated with the
RyR. Jurkat T cells were stimulated as indicated by OKT3 (10 µg/ml). Homogenization, preparation, and solubilization of P10
membranes and immunoprecipitation using anti-RyRcommon
polyclonal antiserum were carried out as described in Fig. 1. Protein
was separated by SDS-PAGE (7.5% separation gel, 3% stacking gel). The
mass of protein in individual lanes corresponds to the mass of RyR
immunoprecipitated by 1 µg of anti-RyRcommon polyclonal
antiserum. Subsequent tank blotting and immunostaining were carried out
as described under "Experimental Procedures." Antibodies used for
immunostaining: left panel, anti-phosphotyrosine
mAb PY 99, middle panel,
anti-p59fyn mAb; right
panel, anti-p56lck mAb (all from
Santa Cruz). Since the signal with anti-p56lck
was more intense as compared with mAb PY 99 or
anti-p59fyn, the exposure time of the
anti-p56lck blot (right
panel) was shortened. This shorter exposure time explains
the lack of (artificial) "staining" of the lower edge of the
blot.
The PTKs implicated in RyR tyrosine phosphorylation,
p56lck and p59fyn, were
then expressed as GST fusion proteins and tested for the ability to
phosphorylate RyR in vitro.
GST-p59fyn and GST-p56lck
both stimulated marked phosphorylation on tyrosine residues of RyR
(Fig. 3). In these experiments P10
membranes were incubated with the GST kinases in the presence of ATP.
Interestingly, the phosphorylation was not transient, as observed
in vivo (Fig. 1), but was stable for at least 20 min. This
indicates loss or inhibition of phosphotyrosine-protein phosphatase(s)
in the P10 preparation on the one hand (kinase assay), or loss of
direct contact of PTKs and RyR during spatial redistribution in
vivo.
|
Jayaraman et al. (16) have reported that
tyrosine phosphorylation of the type 1 InsP3 receptor by
p59fyn in the presence of
Ins(1,4,5)P3 resulted in enhanced channel opening as
measured by single-channel recordings in lipid planar bilayers. Using
permeabilized Jurkat T cells, a well established model to analyze
Ca2+ release by Ins(1,4,5)P3 and cADPR (18,
29), addition of GST-p59fyn, additional GST
fusion proteins, or GST alone prior to addition of cADPR did not have
significant effects on the amplitude of cADPR-mediated
Ca2+-release (Fig. 4,
left panel). In addition, the sensitivity of the
permeabilized T cells to different concentrations of cADPR (0.1 to 10 µM) remained essentially unchanged with prior addition of
GST-p59fyn (data not shown); in other words,
there was no shift in the concentration-response curve for cADPR. Next,
we added GST-p59fyn a few minutes later than
cADPR, a time point where the response to cADPR was still highly active
(Fig. 4, middle panel). Under these conditions,
GST-p59fyn concentration-dependently
evoked additional Ca2+ release. Importantly,
GST-p56lck, GST-Grb2, or GST alone used as
controls only very slightly increased cADPR-mediated Ca2+
release under these conditions (Fig. 4, right
panel). The effect of GST-p59fyn was
due to its catalytic activity because addition of the tyrosine kinase
inhibitor PP2 1 min before addition of
GST-p59fyn concentration-dependently
blocked the enhancing effect of GST-p59fyn
without disturbing the effect of cADPR itself (Table
I). Interestingly, cADPR could be
substituted completely by 4-chloro-3-ethylphenol (4-CEP, Ref. 30) and
partially by Ca2+ ions, known agonists of RyR.
Ca2+ release activated by 4-CEP and Ca2+ was
significantly enhanced by GST-p59fyn (Table
II), indicating that the conformational
change induced by RyR channel opening might be sufficient to make
regulatory tyrosine residues accessible to
GST-p59fyn.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study we have shown that (i) the RyR of T cells is localized in intracellular membrane systems close to the plasma membrane, (ii) the RyR was transiently phosphorylated on Tyr residues upon stimulation of the TCR/CD3 complex, (iii) p59fyn and p56lck were detected in co-immunoprecipitates of the RyR, (iv) recombinant GST fusion proteins of p59fyn and p56lck both phosphorylated immunoprecipitated RyR on tyrosine residues in vitro, and (v) GST-p59fyn, but not GST-p56lck, GST-Grb2, or GST alone, enhanced Ca2+ release by cADPR.
Although phosphorylation on tyrosine residues has not yet been
demonstrated for RyR, there are several reports on phosphorylation of
serine and threonine residues. The type 1 RyR was phosphorylated in vitro by protein kinase A and
Ca2+/calmodulin-dependent protein kinase,
resulting in functional recovery of the channel, which was inhibited by
2.6 mM Mg2+ (31). Similarly, Ser/Thr
phosphorylation also enhanced the sensitivity of the type 1 RyR toward
Ca2+ and ATP (32). The type 2 RyR was phosphorylated by
exogenously added protein kinase A,
Ca2+/calmodulin-dependent protein kinase, and
cyclic GMP-dependent protein kinase. However, the
Ca2+/calmodulin-dependent protein kinase was
much more effective than the other kinases; additionally, endogenous
Ca2+/calmodulin-dependent protein kinase
appears to associate firmly with the type 2 RyR (33). Type 2 RyR
phosphorylation by protein kinase A dissociated FK506-binding protein
12.6 from the channel complex, leading to enhanced channel opening;
importantly, it has been shown in failing hearts that the type 2 RyR is
hyperphosphorylated by protein kinase A, leading to markedly increased
channel opening (34). Pancreatic
-cells also express the type 2 RyR;
in those cells activation of protein kinase A enhanced activation of
RyR by caffeine, 4-chloro-3-ethylphenol, or 3,9-dimethylxanthine (30). Importantly, [3H]ryanodine binding was also found to be
stimulated by phosphorylation of the brain type (type 3) RyR (35).
Analysis of the type 3 RyR amino acid sequence reveals that multiple tyrosine residues, such as tyrosines 810, 1022, 2289, 4045, and 4684, could well be targeted by Src family PTKs, based on the substrate specificity of these kinases (36). Among the potential substrate sites, tyrosines 4045 and 4684 are also good candidates for binding to Src homology 2 domains of Src family PTKs, based on the specificity of phosphotyrosine sequences recognized by various Src homology 2 domains (37).
The observed
p56lck/p59fyn-mediated
tyrosine phosphorylation of RyR is consistent with the notion of the
central role of these PTKs in early events of T cell signaling.
p59fyn and p56lck are
thought to trigger the signal transduction pathways initiated by
TCR/CD3 ligation by phosphorylating cytoplasmic domains of the TCR/CD3
complex and activating other PTKs involved in these events (38, 39).
These PTKs, in turn, phosphorylate phospholipase C-
and linker for
activation of T cells, thus triggering one pathway of Ca2+
mobilization in T cells (38, 39). Furthermore, it has been shown that
p59fyn and p56lck can
phosphorylate phospholipase C-
directly in vitro (40). Therefore, p59fyn and
p56lck play a crucial role in Ca2+
mobilization in T cells. The tyrosine phosphorylation of RyR described
in this report may represent another mechanism by which p59fyn affects Ca2+ concentrations
in T cells in vivo. Interestingly, tyrosine phosphorylation of RyR at the 2-min time point was in the same order of magnitude as
compared with the band likely representing
p59fyn (Fig. 2, left
panel). It is difficult to relate these relative staining
intensities to the proportion of RyR that are actually tyrosine-phosphorylated. However, even a smaller fraction of
tyrosine-phosphorylated RyR may in fact be sufficient to act as a
triggering system for Ca2+-induced
Ca2+-release, thereby also engaging non-phosphorylated RyR.
Thus, such a model is well compatible with a functional role of a
tyrosine-phosphorylated subfraction of RyR during TCR/CD3-mediated
Ca2+ signaling.
Marks and colleagues (16) have shown recently that the type 1 Ins(1,4,5)P3 receptor is tyrosine-phosphorylated in Jurkat T cells upon stimulation of the TCR/CD3 complex. In addition, they could show that this phosphorylation increased the open probability of the isolated Ins(1,4,5)P3 receptor as measured in lipid planar bilayer experiments (16). To investigate a possible similar influence of tyrosine phosphorylation of the RyR of T cells, we have used permeabilized Jurkat T cells (29). In such permeabilized cells, recombinant GST-p59fyn, but not GST-p56lck, GST-Grb2, or GST alone, concentration-dependently and specifically enhanced cADPR-mediated Ca2+ release in the presence of ATP and an ATP-regenerating system. Surprisingly, this effect required initial activation of RyR by cADPR. This activation changed two parameters of the system; first, [Ca2+] was elevated, and second, the RyR Ca2+ channels switched to the open conformation. Thus, one possible explanation would be that an elevated Ca2+ concentration alone is sufficient for the catalytic effect of GST-p59fyn on RyR. However, GST-p59fyn does not require Ca2+ ions for its catalytic activity. On the other hand, it is well demonstrated that Ca2+ ions act as agonists at the RyR and thereby induce a conformational change of the RyR/Ca2+ channel, as visualized by cryo-electron microscopy and subsequent image processing techniques (41). This view is supported by the finding that activation of RyR by the agonists 4-CEP and Ca2+ was enhanced by GST-p59fyn in a similar way as for cADPR. Thus, conformational changes are very likely to result from binding of these three ligands (this statement does not necessary imply that cADPR binds directly to RyR; additional proteins may be involved here). A similar observation was made when the enhancement of Ins(1,4,5)P3 stimulation of the type 1 Ins(1,4,5)P3 receptor from T cells by p59fyn was measured in bilayer experiments. In that case, the effect was observed only at high [Ca2+] at the cytosolic side, indicating a similar Ca2+-mediated conformational change of the type 1 InsP3 receptor (16). Taken together, these data indicate that the tyrosine residue(s) that could theoretically be phosphorylated by GST-p59fyn are not accessible when the RyR Ca2+ channel is in the closed conformation.
In conclusion, we have shown transient tyrosine phosphorylation of the
RyR of T cells in response to stimulation of the TCR/CD3 complex. In
addition, in permeabilized cells Ca2+ release by cADPR and
4-CEP were significantly enhanced by GST-p59fyn.
Our demonstration that the effect of GST-p59fyn
was specific, concentration-dependent, and could be
inhibited by the tyrosine kinase inhibitor PP2 provides strong evidence that tyrosine phosphorylation of RyR may play a crucial role in the
early phase of T cell Ca2+ signaling and thereby may
constitute an additional element of fine tuning of T lymphocyte
Ca2+ signaling. In a broader context, our data provide
first evidence that, in addition to serine/threonine protein kinases,
PTKs are also involved in regulation of RyR.
| |
FOOTNOTES |
|---|
* This work was supported by Deutsche Forschungsgemeinschaft Grants Gu 360/2-4 and Gu 360/2-5 (to A. H. G. and G. W. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. Tel.: 49-40-42803-2828; Fax: 49-40-42803-9880; E-mail: guse@uke.uni-hamburg.de.
Published, JBC Papers in Press, July 20, 2001, DOI 10.1074/jbc.M100715200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: RyR, ryanodine receptor(s); [Ca2+]i, intracellular free Ca2+ concentration; cADPR, cyclic adenosine diphosphoribose; 4-CEP, 4-chloro-3-ethylphenol; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; GST, glutathione S-transferase; Ins(1, 4,5)P3, D-myo-inositol 1,4,5-trisphosphate; mAb, monoclonal antibody; MOPS, 4-morpholinepropanesulfonic acid; PAGE, polyacrylamide gel electrophoresis; PTK, protein-tyrosine kinase(s); TBS, Tris-buffered saline; TCR/CD3, T cell receptor/CD3.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Sutko, J. L., and Airey, J. A. (1996) Physiol. Rev. 76, 1027-1071 |
| 2. | Giannini, G., Conti, A., Mammarella, S., Scrobogna, M., and Sorrentino, V. (1995) J. Cell Biol. 128, 893-904 |
| 3. | Marks, A. R. (1997) Am. J. Physiol. 272, H597-H605 |
| 4. | Reyes-Harde, M., Empson, R., Potter, B. V. L., Galione, A., and Stanton, P. K. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4061-4066 |
| 5. | Endo, M., Tanaka, M., and Ogawa, Y. (1970) Nature 228, 34-36 |
| 6. | Lee, H. C. (1997) Physiol. Rev. 77, 1133-1164 |
| 7. | Guse, A. H. (1999) Cell. Signal. 5, 309-316 |
| 8. | Guse, A. H. (1998) Crit. Rev. Immunol. 18, 419-448 |
| 9. | Premack, B. A., and Gardner, P. (1992) Am. J. Physiol. 263, C1119-C1140 |
| 10. | Timmerman, L. A., Clipstone, N. A., Ho, S. N., Northrop, J. P., and Crabtree, G. R. (1996) Nature 383, 837-840 |
| 11. | Appleby, M. W., Gross, J. A., Cooke, M. P., Levin, S. D., Qian, X., and Perlmutter, R. M. (1992) Cell 70, 751-763 |
| 12. | Burkhardt, A. L., Stealey, B., Rowley, R. B., Mahajan, S., Prendergast, M., Fargnoli, J., and Bolen, J. B. (1994) J. Biol. Chem. 269, 23642-23647 |
| 13. | Stein, P. L., Lee, H. M., Rich, S., and Soriano, P. (1992) Cell 70, 741-750 |
| 14. | Straus, D. B., and Weiss, A. (1992) Cell 70, 585-593 |
| 15. | Guse, A. H., da Silva, C. P., Berg, I., Weber, K., Heyer, P., Hohenegger, M., Ashamu, G. A., Skapenko, A. L., Schulze-Koops, H., Potter, B. V. L., and Mayr, G. W. (1999) Nature 398, 70-73 |
| 16. | Jayaraman, T., Ondrias, K., Ondriasova, E., and Marks, A. R. (1996) Science 272, 1492-1494 |
| 17. | Salazar, E. P., and Rozengurt, E. (1999) J. Biol. Chem. 274, 28371-28378 |
| 18. | Guse, A. H., Roth, E., and Emmrich, F. (1993) Biochem. J. 291, 447-451 |
| 19. | Atherton, T. J., Wilson, S., Morrey, R. I., and Waterfall, A. (1997) Digital Confocal Imaging: Research Report RR333 , Department of Computer Science, University of Warwick, Coventry, United Kingdom |
| 20. | Tsygankov, A. Y., Spana, C., Rowley, R. B., Penhallow, R. C., Burkhardt, A. L., and Bolen, J. B. (1994) J. Biol. Chem. 269, 7792-7800 |
| 21. | Guse, A. H., Roth, E., and Emmrich, F. (1992) Biochem. J. 288, 489-495 |
| 22. | Marchildon, G. A., Casnellie, J. E., Walsh, K. A., and Krebs, E. G. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 7679-7682 |
| 23. | Peters, D. J., McGrew, B. R., Perron, D. C., Liptak, L. M., and Laudano, A. P. (1990) Oncogene 5, 1313-1319 |
| 24. | Koegl, M., Zlatkine, P., Ley, S. C., Courtneidge, S. A., and Magee, A. I. (1994) Biochem. J. 303, 749-753 |
| 25. | Paige, L. A., Nadler, M. J. S., Harrison, M. L., Cassady, J. M., and Geahlen, R. L. (1993) J. Biol. Chem. 268, 8669-8674 |
| 26. | Samelson, L. E., Phillips, A. F., Luong, E. T., and Klausner, R. D. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4358-4362 |
| 27. | Veillette, A., Bookman, M. A., Horak, E. M., Samelson, L. E., and Bolen, J. B. (1989) Nature 338, 257-259 |
| 28. | Tsygankov, A. Y., Broker, B. M., Fargnoli, J., Ledbetter, J. A., and Bolen, J. B. (1992) J. Biol. Chem. 267, 18259-18262 |
| 29. | Guse, A. H., da Silva, C. P., Emmrich, F., Ashamu, G. A., Potter, B. V. L., and Mayr, G. W. (1995) J. Immunol. 155, 3353-3359 |
| 30. | Islam, M. S., Leibiger, I., Leibiger, B., Rossi, D., Sorrentino, V., Ekström, T. J., Westerblad, H., Andrade, F. H., and Berggren, P. O. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 6145-6150 |
| 31. | Hain, J., Nath, S., Mayrleitner, M., Fleischer, S., and Schindler, H. (1994) Biophys. J. 67, 1823-1833 |
| 32. | Herrmann-Frank, A., and Varsanyi, M. (1993) FEBS Lett. 332, 237-242 |
| 33. | Hohenegger, M., and Suko, J. (1993) Biochem. J. 296, 303-308 |
| 34. | Marx, S. O, Reiken, S., Hisamatsu, Y., Jayaraman, T., Burkhoff, D., Rosemblit, N., and Marks, A. R. (2000) Cell 101, 365-376 |
| 35. | McPherson, P. S., and Campbell, K. P. (1993) J. Biol. Chem. 268, 19785-19790 |
| 36. | Zhou, S., Carraway, K. L. r., Eck, M. J., Harrison, S. C., Feldman, R. A., Mohammadi, M., Schlessinger, J., Hubbard, S. R., Smith, D. P., Eng, C., Lorenzo, M. J., Ponder, B. A. J., Mayer, B. J., and Cantley, L. C. (1995) Nature 373, 536-539 |
| 37. | Songyang, Z., Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W. G., King, F., Roberts, T., Ratnofsky, S., Lechleider, R. J., Neel, B. G., Birge, R. B., Fajardo, J. E., Chou, M. M., Hanafusa, H., Schaffhausen, B., and Cantley, L. C. (1993) Cell 72, 767-778 |
| 38. | van Leeuwen, J. E., and Samelson, L. E. (1999) Curr. Opinion Immunol. 11, 242-248 |
| 39. | Chan, A. C., and Shaw, A. S. (1996) Curr. Opinion Immunol. 8, 394-401 |
| 40. | Liao, F., Shin, H. S., and Rhee, S. G. (1993) Biochem. Biophys. Res. Commun. 191, 1028-1033 |
| 41. | Sharma, M. R., Jeyakumar, L. H., Fleischer, S., and Wagenknecht, T. (2000) J. Biol. Chem. 275, 9485-9491 |
This article has been cited by other articles:
![]() |
I. Panfoli, S. Ravera, A. Fabiano, R. Magrassi, A. Diaspro, A. Morelli, and I. M. Pepe Localization of the Cyclic ADP-Ribose-Dependent Calcium Signaling Pathway in Bovine Rod Outer Segments Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 978 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, Q. Zhang, A. Tengholm, and A. Sjoholm Involvement of JAK2 and Src kinase tyrosine phosphorylation in human growth hormone-stimulated increases in cytosolic free Ca2+ and insulin secretion Am J Physiol Cell Physiol, September 1, 2006; 291(3): C466 - C475. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Duthoit, D. J. Mekala, R. S. Alli, and T. L. Geiger Uncoupling of IL-2 Signaling from Cell Cycle Progression in Naive CD4+ T Cells by Regulatory CD4+CD25+ T Lymphocytes J. Immunol., January 1, 2005; 174(1): 155 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, M. Kohler, S.-N. Yang, F. Zhang, O. Larsson, and P.-O. Berggren Growth Hormone Promotes Ca2+-Induced Ca2+ Release in Insulin-Secreting Cells by Ryanodine Receptor Tyrosine Phosphorylation Mol. Endocrinol., July 1, 2004; 18(7): 1658 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cui, S. J. Matkovich, N. deSouza, S. Li, N. Rosemblit, and A. R. Marks Regulation of the Type 1 Inositol 1,4,5-Trisphosphate Receptor by Phosphorylation at Tyrosine 353 J. Biol. Chem., April 16, 2004; 279(16): 16311 - 16316. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kunerth, M. F. Langhorst, N. Schwarzmann, X. Gu, L. Huang, Z. Yang, L. Zhang, S. J. Mills, L.-h. Zhang, B. V.L. Potter, et al. Amplification and propagation of pacemaker Ca2+ signals by cyclic ADP-ribose and the type 3 ryanodine receptor in T cells J. Cell Sci., April 15, 2004; 117(10): 2141 - 2149. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Schwarzmann, S. Kunerth, K. Weber, G. W. Mayr, and A. H. Guse Knock-down of the Type 3 Ryanodine Receptor Impairs Sustained Ca2+ Signaling via the T Cell Receptor/CD3 Complex J. Biol. Chem., December 20, 2002; 277(52): 50636 - 50642. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |